HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-09-12 for HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM manufactured by Accriva Diagnostics.

Event Text Entries

[120108383] This mdr references accriva diagnostics' complaint number (b)(4) for the hemochron signature elite instrument, serial number (b)(4). Accriva diagnostics' complaint number (b)(4) captures the hemochron act+ reagent cuvette lot used during the procedure, which is classified as a child case. Method codes: analysis of production records. Device not returned. Results code: no findings available. Conclusion code: conclusion not yet available. Accriva diagnostics has requested all data required for form 3500a. Fields for which data were not obtainable or are not applicable are intentionally left blank. An instrument evaluation is anticipated. Results of the evaluation will be submitted as mdr 2250033-2018-00021 follow-up #1.
Patient Sequence No: 1, Text Type: N, H10


[120108384] A healthcare professional reported a lower than expected act result with a hemochron signature elite and act+ microcoagulation system during cardiovascular surgery. The signature elite named in this complaint was used during the procedure and act results recorded were as expected until the latter part of the procedure. An act result was 343 seconds, which was an expected result. However, the act result a short time later was recorded as 123 seconds, which was a lower than expected result. After a heparin bolus was administered, an act was assayed on a second hemochron signature elite and act+ system and was recorded as >850 seconds, which was higher than expected. Protamine was administered at the end of the procedure and no adverse events or medical complications were reported. Electronic and liquid qc passed before the procedure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2250033-2018-00021
MDR Report Key7871423
Report SourceHEALTH PROFESSIONAL
Date Received2018-09-12
Date of Report2018-09-12
Date of Event2018-07-19
Date Mfgr Received2018-09-05
Device Manufacturer Date2015-02-27
Date Added to Maude2018-09-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8582632490
Manufacturer G1ACCRIVA DIAGNOSTICS
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM
Generic NameSYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Product CodeJPA
Date Received2018-09-12
Returned To Mfg2018-08-09
Model NumberELITE
Catalog NumberELITE
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerACCRIVA DIAGNOSTICS
Manufacturer Address6260 SRQUENCE DRIVE SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
10 2018-09-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.